Sifting through countless of stocks in the Health Care REITs industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Ventas, Inc., Omega Healthcare Investors or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.
Read on to learn how Ventas, Inc., Omega Healthcare Investors and Inc. compare based on key financial metrics to determine which better meets your investment needs.
About Ventas, Inc., Omega Healthcare Investors and Inc.
Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas’s seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives. Ventas, Inc. was incorporated in 1983 in Delaware, USA.
Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom. As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators. Additionally, Omega has investments in several unconsolidated entities that own 19 facilities. As a source of capital to the healthcare industry, Omega continually evaluates the opportunities, trends and challenges affecting the industry. Our goal is to identify long-term investments in quality healthcare properties with outstanding operators that provide the most favorable risk/reward ratio to our investors.
Latest Health Care REITs and Ventas, Inc., Omega Healthcare Investors, Inc. Stock News
As of May 7, 2026, Ventas, Inc. had a $42.1 billion market capitalization, compared to the Health Care REITs median of $3.6 million. Ventas, Inc.’s stock is up 12.8% in 2026, down 0.8% in the previous five trading days and up 31.48% in the past year.
Currently, Ventas, Inc.’s price-earnings ratio is 158.2. Ventas, Inc.’s trailing 12-month revenue is $6.1 billion with a 4.3% net profit margin. Year-over-year quarterly sales growth most recently was 21.9%. Analysts expect adjusted earnings to reach $0.610 per share for the current fiscal year. Ventas, Inc. currently has a 2.4% dividend yield.
As of May 7, 2026, Omega Healthcare Investors, Inc. had a $13.7 billion market cap, putting it in the 82nd percentile of all stocks. Omega Healthcare Investors, Inc.’s stock is up 5.3% in 2026, down 0.6% in the previous five trading days and up 28.5% in the past year.
Currently, Omega Healthcare Investors, Inc.’s price-earnings ratio is 22.4. Omega Healthcare Investors, Inc.’s trailing 12-month revenue is $1.2 billion with a 51.1% net profit margin. Year-over-year quarterly sales growth most recently was 16.7%. Analysts expect adjusted earnings to reach $2.009 per share for the current fiscal year. Omega Healthcare Investors, Inc. currently has a 5.8% dividend yield.
How We Compare Ventas, Inc., Omega Healthcare Investors and Inc. Stock Grades
Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Ventas, Inc., Omega Healthcare Investors and Inc.’s stock grades to see how they measure up against one another.
Learn more about A+ Investor here!
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
Ventas, Inc., Omega Healthcare Investors and Inc. Stock Value Grades
| Company | Ticker | Value |
| Ventas, Inc. | VTR | F |
| Omega Healthcare Investors, Inc. | OHI | D |
Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.
Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.
AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.
Ventas, Inc. has a Value Score of 7, which is Ultra Expensive.
Omega Healthcare Investors, Inc. has a Value Score of 22, which is Expensive.
The Value Stock Winner: No Clear Winner
Neither Ventas, Inc., Omega Healthcare Investors or Inc. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Ventas, Inc., Omega Healthcare Investors or Inc. is the better investment when it comes to value.
Ventas, Inc., Omega Healthcare Investors and Inc. Growth Grades
| Company | Ticker | Growth |
| Ventas, Inc. | VTR | A |
| Omega Healthcare Investors, Inc. | OHI | A |
The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.
In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.
The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.
Ventas, Inc. has a Growth Score of 100, which is Very Strong.
Omega Healthcare Investors, Inc. has a Growth Score of 95, which is Very Strong.
The Growth Grade Winner: It’s a Tie!
Looking at the Growth Grade breakdown above, both Ventas, Inc., Omega Healthcare Investors and Inc. have a grade of A. For investors who focus solely on a company’s upward growth, further research should be conducted into both companies’ other financial metrics before deciding whether to invest.
Ventas, Inc., Omega Healthcare Investors and Inc.’s Quality Grades
| Company | Ticker | Quality |
| Ventas, Inc. | VTR | C |
| Omega Healthcare Investors, Inc. | OHI | C |
Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.
The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.
The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.
Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.
Ventas, Inc. has a Quality Score of 41, which is Average.
Omega Healthcare Investors, Inc. has a Quality Score of 59, which is Average.
The Quality Stock Winner: No Clear Winner
Neither Ventas, Inc., Omega Healthcare Investors or Inc. has a high enough Quality Grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolios. It’s important to look at a wide range of financial metrics in order to determine if Ventas, Inc., Omega Healthcare Investors or Inc. is the better investment when it comes to quality.
Don’t Forget Your Free Special Report on How A+ Grades Can Help You Make Investment Decisions
Other Ventas, Inc., Omega Healthcare Investors and Inc. Grades
In addition to Quality, Value and Growth, A+ Investor also provides grades for Momentum and Estimate Revisions.
Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.
Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).
These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Ventas, Inc., Omega Healthcare Investors and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.
So, Which Is the Better Investment, Ventas, Inc., Omega Healthcare Investors or Inc. Stock?
Overall, Ventas, Inc. stock has a Value Score of 7, Growth Score of 100 and Quality Score of 41.
Omega Healthcare Investors, Inc. stock has a Value Score of 22, Growth Score of 95 and Quality Score of 59.
Comparing Ventas, Inc., Omega Healthcare Investors and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.
Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.
A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.